Article Abstract

Volume 27, No. (2), 2017 (April)
EFFECTS OF FEVERFEW (TANACETUM PARTHENIUM) AND ANTIBIOTIC CO-ADMINISTRATION ON BLOOD NEUTROPHIL FUNCTION AND SERUM PROCALCITONIN IN DOGS WITH EXPERIMENTAL SUBCUTANEOUS PSEUDOMONAS AERUGINOSA INFECTION
M. Andonova1*, E. Slavov1, P. Dzhelebov1, V. Urumova2, D. Dimitrova3 and M. Lyutskanov2

M. Andonova1*, E. Slavov1,  P. Dzhelebov1, V. Urumova2, D. Dimitrova3 and M. Lyutskanov2

1Department of General and Clinical Pathology,

2Department of Veterinary Microbiology, Infectious and Parasitic Diseases,

3Department of Pharmacology, Animal Physiology and Physiological Chemistry, Faculty of Veterinary Medicine, Trakia University, Bulgaria

Corresponding Author: andonova_m@yahoo.com
DOI: N/A
Page Number(s): 430-438
Published Online First: April 01, 2017
Publication Date: April 01, 2017
ABSTRACT

The control of experimental canine Pseudomonas aeruginosa infection was optimised via a combined therapy including enrofloxacin against the bacteria and parthenolide (active component of the plant Tanacetum parthenium) for correction of inflammatory reaction. The aim of the present study was to evaluate the effect of this therapy on absolute neutrophil counts (ANC), blood neutrophilic function (phagocytosis, oxidative burst activity), serum naturally occurring antibodies (NAbs), procalcitonin (PCT) in infected animals. Blood samples were collected prior to the infection – hour 0 and post infection hours 4, 24, 48, 72 and day 7 from 25 male dogs, divided into five equal groups. Group C included healthy dogs (negative control). Dogs from Group 0 were injected subcutaneously with P. aeruginosa bacterial culture (1×108 CFU/mL) and untreated (positive control). The infected dogs from group I were treated s.c. with enrofloxacin on post infection hour 48 at 5 mg/kg. Dogs from Group II were treated beginning from the 4th hour post infection with standardized feverfew extract – 90 mg, 0.7% parthenolidegiven orally at 2 capsules daily for 6 days. Group III included

Keywords: Dogs, Pseudomonas aeruginosa infection, Neutrophil functions, Therapy

Indexing

Web of Science (SCIE)

SCOPUS (Q3)

Status

Journal Metrics

Journal Impact Factor: 0.5 | (JCR Year: 2025) | Cite Score: 1.3

HEC Category: W

Current

ISSN Details

Print ISSN: 1018-7081

Electronic ISSN: 2309-8694

Verified
Search the Journal

Use the fields below to search for articles by Title, Author, or Keywords.